Inflammatory Bowel Disease (IBD) Diagnosis and Management

Introduction to IBD

The American Gastroenterological Association suggests that the triad of erythema nodosum, Achilles tendon enthesitis, and sacroiliitis strongly suggests inflammatory bowel disease (IBD) as the underlying etiology 1, 2

Erythema nodosum occurs in 4.2-7.5% of IBD patients, more commonly in Crohn's disease than ulcerative colitis, and typically correlates with intestinal disease activity 1, 3
Radiological sacroiliitis is present in 20-50% of IBD patients, though progressive ankylosing spondylitis develops in only 1-10% 1

The European Society of Gastrointestinal Endoscopy recommends obtaining detailed gastrointestinal history: chronic diarrhea, abdominal pain, rectal bleeding, weight loss, or perianal disease 1, 2
Laboratory evaluation should include complete blood count, inflammatory markers, and fecal calprotectin 2
Colonoscopy with biopsies is the gold standard for diagnosing IBD if not previously established 2
MRI of sacroiliac joints using T1-weighted, STIR, and fat-saturated T2-weighted sequences to confirm sacroiliitis, especially in patients under 40 years with inflammatory back pain lasting >3 months 1

The American College of Gastroenterology recommends systemic corticosteroids for severe erythema nodosum associated with IBD flares 2, 3
Immunomodulators or biologic agents are indicated for frequent relapses or resistant cases 2, 3
TNF-α monoclonal antibodies are preferred over etanercept for IBD-associated spondyloarthropathy 6, 7

Erythema nodosum: NSAIDs for symptomatic relief, rest, elevation; treatment of underlying IBD typically leads to resolution 2, 3
Enthesitis: NSAIDs, physical therapy, local corticosteroid injections if refractory 1, 8
Sacroiliitis/axial symptoms: NSAIDs as first-line; TNF-α inhibitors if inadequate response 2, 6, 7

Do not assume erythema nodosum is idiopathic when accompanied by enthesitis and sacroiliitis—this triad mandates investigation for IBD 1, 2
Do not use NSAIDs liberally without considering IBD, as they can exacerbate intestinal inflammation in some patients 2
Do not delay colonoscopy if gastrointestinal symptoms are present or if the patient has unexplained anemia or elevated inflammatory markers 2
HLA-B27 testing has limited utility in IBD-associated spondyloarthropathy, so negative results do not exclude the diagnosis 1